Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
California medical device maker TriVascular Technologies is looking to raise as much as $100 million through its initial public offering, the details of which have yet to be finalized.
The stent graft maker said in registration documents that it plans to use the funds to repay a $3.5 million promissory note, plus interest, to medtech titan Boston Scientific. Additional funds will go toward sales & marketing efforts, expanded R&D and general corporate operations. Read more
Five people with an unusual pattern of brain folds have afforded a glimpse into how the human brain may have evolved its language capabilities.
How the human brain develops its hills and valleys — expanding its surface area and computational capacity — has been difficult to study. Mice, the staple of scientific research, lack folds in their brains. Read more
Philips Healthcare subsidiary Respironics got the FDA’s highest-level warning over a recall of certain Trilogy ventilators.
The devices were recalled over concerns that they may fail to provide breathing support. Respironics attributed the error to a faulty component on the device’s power management board, discovered during production testing. Read more